Myriad Genetics (MYGN) Q4 Earnings and Revenues Surpass Estimates

Myriad Genetics (MYGN) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +350.00%. A quarter ago, it was expected that this molecular diagnostic company would post a loss of $0.01 per share when it actually produced break-even earnings, delivering a surprise of +100%.Over the ...